FDA小组指出孕期抗抑郁药风险，但医生强调这些风险对孕产妇健康至关重要。 FDA panel flags antidepressant risks in pregnancy, but doctors stress they’re vital for maternal health.

林业发展局最近的一个咨询小组对怀孕期间使用抗抑郁药表示关切,并列举了胎儿发育的潜在风险。 A recent FDA advisory panel raised concerns about the use of antidepressants during pregnancy, citing potential risks to fetal development. 然而,许多保健提供者强调,这些药物对于管理孕产妇心理健康至关重要,往往成为抑郁症或焦虑症孕妇的一条生命线。 However, many healthcare providers emphasize that these medications are essential for managing maternal mental health, often serving as a lifeline for pregnant individuals with depression or anxiety. 医生强调,未经治疗的精神疾病对母亲和儿童都构成重大危险,他们敦促作出谨慎的、个性化的治疗决定。 Doctors stress that untreated mental illness poses significant dangers to both mother and child, and they urge careful, individualized treatment decisions.